百济神州(06160.HK)与Strand Therapeutics达成mRNA疗法战略合作
百济神州(06160.HK)公布,与生物制药公司Strand Therapeutics达成合作,双方将共同开发和商业化Strand新型、多功能mRNA疗法於实体瘤的治疗。百济神州已获得在亚洲(除日本以外)、澳洲和新西兰开发和商业化至多两款肿瘤免疫项目的选择权,项目将利用Strand的瘤内或全身性传递机制,将具备改变肿瘤微环境能力的mRNA直接传递至肿瘤病灶。
百济神州高级副总裁兼外部创新负责人罗侣松预计,合作有助公司在抗肿瘤领域推出新型的基於mRNA的肿瘤免疫疗法。根据协议条款,Strand将获得500万美元的现金预付款,同时可获得共计至多2,800万美元的额外近期付款,以及销售里程碑及授权地区的分级产品销售特许使用费。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.